NORTHERN BIOLOGICS INC.
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. Its therapeutic antibody candidates are derived from a state-of-the-art phage display platform developed and refined by world-leading researchers at the University of Toronto, and we focus on developing novel functional modulators of key signaling pathways in cancer and fibrosis. Northern Biologics was founded in 2014 and headquartered in Toronto, Ontario, Canada.
NORTHERN BIOLOGICS INC.
Social Links:
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.northernbiologics.com
Total Employee:
11+
Status:
Closed
Contact:
(416)634-7132
Email Addresses:
[email protected]
Total Funding:
7.29 M USD
Technology used in webpage:
SPF LetsEncrypt Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL Oracle Cloud NSONE
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2016-12-01 | Mosaic Biomedicals | Mosaic Biomedicals acquired by Northern Biologics Inc. | N/A |
Investors List
Sixty Degree Capital
Sixty Degree Capital investment in Venture Round - Northern Biologics Inc.
Official Site Inspections
http://www.northernbiologics.com
- Host name: 39.240.198.66.in-addr.arpa
- IP address: 66.198.240.39
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
More informations about "Northern Biologics Inc." on Search Engine
Versant Ventures | Northern Biologics
Northern Biologics was the first company built through the Blueline Bioscience incubator, and serves as a case study about the necessary ingredients to turn academic science and entrepreneurial insights into a โฆSee details»
Northern Biologics Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Northern Biologics. Use the PitchBook Platform to explore the full profile.See details»
Northern Biologics: new biotech company to develop โฆ
Launched with a $10 million investment from Versant, Northern Biologics is a joint creation of U of T, the University Health Network's Princess Margaret Cancer Centre and Versant's biotech incubator, Blueline โฆSee details»
BI Expands Immuno-oncology Portfolio | Boehringer Ingelheim US
Ingelheim, Germany and Toronto, Canada โ 14 May 2020 โ Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of โฆSee details»
UHN spin-off company part of big deal in cancer โฆ
May 14, 2020 Northern Biologics Inc., a UHN spin-off and developer of antibody-based therapeutics, was acquired Thursday by Boehringer Ingelheim (BI), the world's largest private pharmaceutical company. โฆSee details»
Northern Biologics, Mosaic Biomedicals Execute Transformative โฆ
Dec 19, 2016 Following the transactions, Northern Biologics has full funding for the early clinical development of MSC-1, in addition to its preclinical portfolio of therapeutic โฆSee details»
Northern Biologics Start-up | UHN Research
Northern Biologics Start-up. Novel cancer drugs to be developed in Toronto. In one of the biggest biotech deals in Canada, UHN and its partners announced the launch of its โฆSee details»
Boehringer Ingelheim acquires Northern Biologics to expand โฆ
May 18, 2020 Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which โฆSee details»
Boehringer Ingelheim acquires Canada's Northern Biologics
May 14, 2020 Boehringer Ingelheim Corp. acquired Toronto-based Northern Biologics Inc., including its cancer programs aimed at developing antibodies for the tumor โฆSee details»
Boehringer Ingelheim Acquires Northern Biologicsโ Preclinical โฆ
May 14, 2020 The Northern Biologics-Boehringer Ingelheim acquisition represents the second recent transaction for a Versant-built company operating out of the MaRS โฆSee details»
Boehringer Ingelheim Acquires Northern Biologics' Preclinical โฆ
May 14, 2020 The programs acquired by Boehringer Ingelheim were discovered and translated into clinical candidates by Northernโs Toronto-based research team. โฆSee details»
Northern Biologics Inc. acquired by Boehringer Ingelheim
Acquired Organization: Northern Biologics Inc. Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. โฆSee details»
Northern Biologics Inc Company Profile | Toronto, ON, Canada ...
Find company research, competitor information, contact details & financial data for Northern Biologics Inc of Toronto, ON. Get the latest business insights from Dun & โฆSee details»
Northern Biologics Inc. - Funding, Financials, Valuation & Investors
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis.See details»
A Big Deal for Cancer Therapeutics | UHN Research
Northern Biologics Inc., a UHN spin-off and developer of antibody-based therapeutics, was acquired today by Boehringer Ingelheim (BI), the worldโs largest private pharmaceutical โฆSee details»
Northern Biologics Strikes a Deal | UHN Research
Northern Biologics, a privately held company that is commercializing antibody therapeutics developed at UHN and the University of Toronto, announced this week that it has โฆSee details»
About BioLogics Inc - Ultrasonic Homogenizers - Sonicators - Cell ...
We envisioned improving customer efficiency and accuracy by automating manual processes. With our extensive market experience, strong customer networks, and โฆSee details»
Biologics, Inc. Company Profile | Warrenton, VA | Competitors ...
View D&B Scores & Ratings. Find company research, competitor information, contact details & financial data for Biologics, Inc. of Warrenton, VA. Get the latest business โฆSee details»
BioLogics Inc - Ultrasonic Homogenizers - Sonicators - Cell โฆ
For the Drug Discovery researcher, we manufacture automated systems for sensitivity testing ( tumor colony analyzer) of chemotherapeutic or radiation therapeutic agents. For โฆSee details»
Northern Biologics - Products, Competitors, Financials, โฆ
Northern Biologics develops therapeutic antibodies for the treatment of human diseases in oncology and fibrosis. On May 18, 2020, Northern Biologics was acquired by โฆSee details»